跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

Selective Killing: How Chemotherapy Harms Cancer Cells More Than Normal Cells

1The Selectivity Problem: Why Preferential Killing Is Possible but Imperfect2Proliferation as the Primary Vulnerability: Cell-Cycle Dependence3Antimetabolites and the S-Phase Trap4Microtubule Poisons and Mitotic Arrest5DNA-Damaging Agents: Alkylators, Crosslinkers, and Topoisomerase Poisons6The DNA-Damage Response and the Decision to Die7Why Selectivity Fails: Normal-Tissue Toxicity and the Limits of the Window8Resistance: How Tumors Escape and What It Reveals About Selectivity9Widening the Window: Clinical Strategies That Exploit Selectivity
DNA-Damaging Agents: Alkylators, Crosslinkers, and Topoisomerase Poisons

Three Ways to Damage DNA: Alkylation, Crosslinking, and Topoisomerase Trapping

1 / 2
Look at the three panels as three different ways of leaving a mark on DNA. In the first, an alkylating agent has attached a small chemical group to a guanine base — a monofunctional adduct. If the drug has two reactive ends, it can grab two sites at once, and when those sites sit on opposite strands you get an interstrand crosslink, a covalent staple holding the duplex together. Cisplatin reaches the same endpoint by a different route: its platinum center loses its chlorides, becomes reactive, and links two adjacent guanines on the same strand, bending the helix. The third panel is the odd one out. Here the DNA is broken, but a topoisomerase enzyme is still covalently attached to the broken end. That is the trapped cleavage complex. Notice that in the first two panels the drug is the lesion; in the third, the drug has turned a normal, transient enzyme intermediate into a persistent one.
0:00 / 0:00

DNA-damaging chemotherapeutics fall into three mechanistically distinct groups, and the distinction matters because each produces a different kind of lesion with a different consequence.

Alkylating agents are electrophiles that transfer an alkyl group to a nucleophilic site on a DNA base. The most reactive positions are the N7 and O6 of guanine, and the N3 of adenine. A monofunctional alkylator adds one group and produces a base adduct that can mispair during replication. A bifunctional alkylator, such as cyclophosphamide's active metabolite phosphoramide mustard or chlorambucil, carries two reactive groups and can react twice, linking two nucleophilic sites. When the two sites are on opposite strands, the result is an interstrand crosslink, a covalent bridge that holds the two strands together. When they are on the same strand, the result is an intrastrand crosslink or an intrastrand adduct.

Platinum coordination complexes, principally cisplatin, carboplatin, and oxaliplatin, are not alkylators in the strict chemical sense, but they produce the same functional lesion. Cisplatin's square-planar platinum(II) center carries two labile chloride leaving groups. Inside the cell, where chloride concentration is low, water displaces the chlorides and the activated platinum coordinates to the N7 of two adjacent guanines, forming a 1,2-intrastrand crosslink that bends and unwinds the helix. Roughly 90 percent of cisplatin adducts are of this intrastrand type, with interstrand crosslinks a minority. The chemistry differs from an alkylator; the biological consequence — a covalent, helix-distorting bridge — does not.

Topoisomerase poisons work by an entirely different principle. Topoisomerase I nicks one strand, allows it to rotate around the intact strand, and religates it; topoisomerase II cuts both strands, passes another duplex through the gap, and religates. Both enzymes form a transient covalent tyrosyl–phosphate bond to the DNA as part of the normal catalytic cycle. A poison such as irinotecan's active metabolite SN-38 (topoisomerase I) or etoposide (topoisomerase II) intercalates at the enzyme–DNA interface and stabilizes the cleavage complex, slowing religation. The strand break, normally transient, becomes persistent and protein-linked. This is the crucial distinction from a simple DNA binder: a poison does not merely occupy the helix, it traps the enzyme in a state the cell must actively resolve.

上一页1 / 2下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion